Two Giants Vie for Billions in S.T.D. Vaccine Market
Thursday, September 10, 2009 - 01:07
in Health & Medicine
Merck and GlaxoSmithKline, with the support of federal panels, plan to expand use of their treatments against the human papillomavirus.